MBOT

SEC source: 0001493152-26-015148 · ownership.xml · derivative · entry 1

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2036-04-01

SEC source: 0001493152-26-015149 · ownership.xml · derivative · entry 1

Stockburger Aileen Ptucha · CIK 0001806682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2036-04-01

SEC source: 0001493152-26-015147 · ownership.xml · derivative · entry 1

Wenderow Tal Baruch · CIK 0001822324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2036-04-01

SEC source: 0001493152-26-015146 · ownership.xml · derivative · entry 1

Wilson David James · CIK 0002052349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2036-04-01

SEC source: 0001493152-26-015151 · ownership.xml · derivative · entry 1

Burell Scott R · CIK 0001399318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2036-04-01

SEC source: 0001493152-26-015150 · ownership.xml · derivative · entry 1

Laxminarain Prattipati · CIK 0001725204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2036-04-01

SEC source: 0001493152-26-007612 · ownership.xml · derivative · entry 1

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 480,000

Underlying: Common Stock, par value $0.01 per share · 480,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the "Plan"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan.

SEC source: 0001493152-26-007613 · ownership.xml · derivative · entry 1

Diaz-Cartelle Juan · CIK 0002001881 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock, par value $0.01 per share · 105,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the "Plan"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan.

SEC source: 0001493152-26-007610 · ownership.xml · derivative · entry 1

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock, par value $0.01 per share · 105,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the "Plan"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan.

SEC source: 0001493152-26-007611 · ownership.xml · derivative · entry 1

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock, par value $0.01 per share · 105,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the "Plan"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan.

SEC source: 0001493152-25-005407 · ownership.xml · derivative · entry 1

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,000

Underlying: Common Stock, par value $0.01 per share · 228,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-25-005409 · ownership.xml · derivative · entry 1

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,125

Underlying: Common Stock, par value $0.01 per share · 48,125 shares

Expires 2035-02-05

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-25-005408 · ownership.xml · derivative · entry 1

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Common Stock, par value $0.01 per share · 43,750 shares

Expires 2035-02-05

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-25-005406 · ownership.xml · derivative · entry 1

Diaz-Cartelle Juan · CIK 0002001881 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock, par value $0.01 per share · 42,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-25-004279 · ownership.xml · derivative · entry 1

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2035-01-28

SEC source: 0001493152-25-004278 · ownership.xml · derivative · entry 1

Burell Scott R · CIK 0001399318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2035-01-28

SEC source: 0001493152-25-004277 · ownership.xml · derivative · entry 1

Wenderow Tal Baruch · CIK 0001822324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2035-01-28

SEC source: 0001493152-25-004276 · ownership.xml · derivative · entry 1

Wilson David James · CIK 0002052349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock, par value $0.01 per share · 20,000 shares

Expires 2035-01-28

SEC source: 0001493152-25-004275 · ownership.xml · derivative · entry 1

Laxminarain Prattipati · CIK 0001725204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2035-01-28

SEC source: 0001493152-25-004280 · ownership.xml · derivative · entry 1

Stockburger Aileen Ptucha · CIK 0001806682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.01 per share · 10,000 shares

Expires 2035-01-28

SEC source: 0001493152-24-007871 · ownership.xml · derivative · entry 3

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,567

Underlying: Common Stock, par value $0.01 per share · 79,567 shares

Expires 2034-02-26

SEC source: 0001493152-25-005407 · ownership.xml · derivative · entry 2

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock, par value $0.01 per share · 12,000 shares

Expires 2034-02-26

F2 · date: Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 12,000 options have been met and, accordingly, vested.

SEC source: 0001493152-25-005409 · ownership.xml · derivative · entry 2

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,375

Underlying: Common Stock, par value $0.01 per share · 4,375 shares

Expires 2034-02-26

F2 · date: Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 4,375 options have been met and, accordingly, vested.

SEC source: 0001493152-25-005408 · ownership.xml · derivative · entry 2

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock, par value $0.01 per share · 8,750 shares

Expires 2034-02-26

F2 · date: Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 8,750 options have been met and, accordingly, vested.

SEC source: 0001493152-25-005406 · ownership.xml · derivative · entry 2

Diaz-Cartelle Juan · CIK 0002001881 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,500

Underlying: Common Stock, par value $0.01 per share · 10,500 shares

Expires 2034-02-26

F2 · date: Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 10,500 options have been met and, accordingly, vested.

SEC source: 0001493152-24-007870 · ownership.xml · derivative · entry 1

Diaz-Cartelle Juan · CIK 0002001881 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-24-007872 · ownership.xml · derivative · entry 2

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2034-02-22

SEC source: 0001493152-24-007872 · ownership.xml · derivative · entry 1

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-24-007873 · ownership.xml · derivative · entry 2

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2034-02-22

SEC source: 0001493152-24-007873 · ownership.xml · derivative · entry 1

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-24-007871 · ownership.xml · derivative · entry 2

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock, par value $0.01 per share · 80,000 shares

Expires 2034-02-22

SEC source: 0001493152-24-007871 · ownership.xml · derivative · entry 1

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock, par value $0.01 per share · 80,000 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-039530 · ownership.xml · derivative · entry 1

Burell Scott R · CIK 0001399318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,218

Underlying: Common Stock, par value $0.01 per share · 74,218 shares

Expires 2033-11-02

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-039531 · ownership.xml · derivative · entry 1

Bornstein Yoseph · CIK 0001690100 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,218

Underlying: Common Stock, par value $0.01 per share · 74,218 shares

Expires 2033-11-02

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-039529 · ownership.xml · derivative · entry 1

Wenderow Tal Baruch · CIK 0001822324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,218

Underlying: Common Stock, par value $0.01 per share · 74,218 shares

Expires 2033-11-02

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-039528 · ownership.xml · derivative · entry 1

Stockburger Aileen Ptucha · CIK 0001806682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,218

Underlying: Common Stock, par value $0.01 per share · 74,218 shares

Expires 2033-11-02

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-039526 · ownership.xml · derivative · entry 1

Laxminarain Prattipati · CIK 0001725204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,218

Underlying: Common Stock, par value $0.01 per share · 74,218 shares

Expires 2033-11-02

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-039527 · ownership.xml · derivative · entry 1

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,218

Underlying: Common Stock, par value $0.01 per share · 74,218 shares

Expires 2033-11-02

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-026630 · ownership.xml · derivative · entry 1

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock, par value $0.01 per share · 80,000 shares

Expires 2033-08-01

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on February 1, 2024, the options shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-026631 · ownership.xml · derivative · entry 1

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2033-08-01

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-026629 · ownership.xml · derivative · entry 1

Morag Eyal · CIK 0001805787 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2033-08-01

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-026628 · ownership.xml · derivative · entry 1

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock, par value $0.01 per share · 17,500 shares

Expires 2033-08-01

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-001824 · ownership.xml · derivative · entry 1

Morag Eyal · CIK 0001805787 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock, par value $0.01 per share · 35,000 shares

Expires 2033-01-17

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on July 17, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-001822 · ownership.xml · derivative · entry 1

Sharon Simon · CIK 0001851272 · General Manager, CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock, par value $0.01 per share · 35,000 shares

Expires 2033-01-17

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on July 17, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

SEC source: 0001493152-23-000874 · ownership.xml · derivative · entry 1

Gadot Harel · CIK 0001690103 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock, par value $0.01 per share · 160,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on June 21, 2023, the options shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-23-000884 · ownership.xml · derivative · entry 1

Vaknin Rachel · CIK 0001923217 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock, par value $0.01 per share · 13,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on June 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-22-026696 · ownership.xml · derivative · entry 1

Stockburger Aileen Ptucha · CIK 0001806682 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,637

Underlying: Common Stock, par value $0.01 per share · 16,637 shares

Expires 2032-09-21

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-22-026614 · ownership.xml · derivative · entry 1

Bornstein Yoseph · CIK 0001690100 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,637

Underlying: Common Stock, par value $0.01 per share · 16,637 shares

Expires 2032-09-21

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-22-026613 · ownership.xml · derivative · entry 1

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,637

Underlying: Common Stock, par value $0.01 per share · 16,637 shares

Expires 2032-09-21

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

SEC source: 0001493152-22-026612 · ownership.xml · derivative · entry 1

Wenderow Tal Baruch · CIK 0001822324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,637

Underlying: Common Stock, par value $0.01 per share · 16,637 shares

Expires 2032-09-21

F1 · derivative.exercise_date: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.